Business Wire

Strand Therapeutics Presents Preclinical Data on Programmable mRNA Therapy STX-001 at AACR 2023

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, announced today preclinical data from its programmable mRNA ...
FierceBiotech

Strand's Big Pharma-backed series B brings in $153M to advance mRNA tumor drugs

An impressive array of Big Pharma backers lined up to ensure Strand Therapeutics has the funding needed to take its mRNA-based solid tumor drug further into the clinic. New Strand supporters that ...
Business Wire

Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for Solid Tumors

BOSTON--(BUSINESS WIRE)--Strand Therapeutics, the world’s first programmable mRNA company developing curative therapies for cancer, autoimmune diseases, and beyond, today announced the first patient ...
The Business Journals

MIT spinout raises $153M for 'programmable' mRNA drugs

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boston biotech that was born ...
News Medical

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

In a recent article published in the journal Nature, researchers used a classical concept in computational linguistics to design a new algorithm, LinearDesign, which optimized the structural stability ...